[1]
G. V. Dzyak, K. Y. Yegorov, and E. L. Kolesnik, “Pitavastatin – a new inhibitor of the HMG-CoA reductase: peculiarities of clinical pharmacology and perspectives of its usage in treatment of cardiovascular diseases”., Med. perspekt., vol. 18, no. 4, pp. 36–44, Dec. 2013.